These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30891964)

  • 1. Prognostic Implication of Ventricular Conduction Disturbance Pattern in Hospitalized Patients with Acute Heart Failure Syndrome.
    Lee JH; Park JJ; Cho Y; Oh IY; Yoo BS; Kim JJ; Kim KH; Kang SM; Baek SH; Jeon ES; Cho MC; Chae SC; Oh BH; Choi DJ
    Korean Circ J; 2019 Jul; 49(7):602-611. PubMed ID: 30891964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship of Conduction Disorder and Prognosis in Patients with Acute Coronary Syndrome.
    Lee WC; Fang YN; Chen TY; Hsieh YY; Tsai YH; Fang HY; Wu PJ; Chen HC; Liu PY
    Int J Clin Pract; 2022; 2022():9676434. PubMed ID: 36340965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block.
    Kawata H; Bao H; Curtis JP; Minges KE; Mitiku T; Birgersdotter-Green U; Feld GK; Hsu JC
    J Am Coll Cardiol; 2019 Jun; 73(24):3082-3099. PubMed ID: 31221257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) study.
    Zhang ZM; Rautaharju PM; Soliman EZ; Manson JE; Martin LW; Perez M; Vitolins M; Prineas RJ
    Circ Heart Fail; 2013 Jul; 6(4):655-61. PubMed ID: 23729198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block.
    Scholz EP; Fischer P; Lugenbiel P; Xynogalos P; Schweizer PA; Scherer D; Thomas D; Katus HA; Zitron E
    J Interv Card Electrophysiol; 2018 Dec; 53(3):347-355. PubMed ID: 30232686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
    Kristensen SL; Castagno D; Shen L; Jhund PS; Docherty KF; Rørth R; Abraham WT; Desai AS; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Eur J Heart Fail; 2020 Dec; 22(12):2370-2379. PubMed ID: 32720404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive Left Ventricular Activations Associated With ECG Pattern in Heart Failure Patients.
    Derval N; Duchateau J; Mahida S; Eschalier R; Sacher F; Lumens J; Cochet H; Denis A; Pillois X; Yamashita S; Komatsu Y; Ploux S; Amraoui S; Zemmoura A; Ritter P; Hocini M; Haissaguerre M; Jaïs P; Bordachar P
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction.
    Varma N
    Am J Cardiol; 2009 Jun; 103(11):1578-85. PubMed ID: 19463519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Cannon JA; Shen L; Jhund PS; Anand IS; Komajda M; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2016 Aug; 18(8):1021-31. PubMed ID: 27194023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Progressive Intraventricular Conduction Disturbance and Cardiovascular Events.
    Hayashi H; Wu Q; Horie M
    PLoS One; 2016; 11(7):e0157412. PubMed ID: 27391877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure.
    Barsheshet A; Leor J; Goldbourt U; Garty M; Schwartz R; Behar S; Luria D; Eldar M; Glikson M
    Am J Cardiol; 2008 May; 101(9):1303-8. PubMed ID: 18435962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of bundle branch block to long-term (four-year) mortality in hospitalized patients with systolic heart failure.
    Barsheshet A; Goldenberg I; Garty M; Gottlieb S; Sandach A; Laish-Farkash A; Eldar M; Glikson M
    Am J Cardiol; 2011 Feb; 107(4):540-4. PubMed ID: 21184999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry.
    Lund LH; Benson L; Ståhlberg M; Braunschweig F; Edner M; Dahlström U; Linde C
    Eur J Heart Fail; 2014 Oct; 16(10):1073-81. PubMed ID: 25201219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular conduction defects and the risk of incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study.
    Zhang ZM; Rautaharju PM; Prineas RJ; Loehr L; Rosamond W; Soliman EZ
    J Card Fail; 2015 Apr; 21(4):307-12. PubMed ID: 25582389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular electromechanical delay in patients with heart failure and normal QRS duration and in patients with right and left bundle branch block.
    Badano LP; Gaddi O; Peraldo C; Lupi G; Sitges M; Parthenakis F; Molteni S; Pagliuca MR; Sassone B; Di Stefano P; De Santo T; Menozzi C; Brignole M
    Europace; 2007 Jan; 9(1):41-7. PubMed ID: 17224421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electroanatomic mapping system.
    Fantoni C; Kawabata M; Massaro R; Regoli F; Raffa S; Arora V; Salerno-Uriarte JA; Klein HU; Auricchio A
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):112-9; discussion 120-1. PubMed ID: 15720446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    J Hypertens; 2019 Mar; 37(3):629-635. PubMed ID: 30676480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of QRS morphology in determining the prevalence of mechanical dyssynchrony in heart failure patients eligible for cardiac resynchronization: particular focus on patients with right bundle branch block with and without coexistent left-sided conduction defects.
    Haghjoo M; Bagherzadeh A; Farahani MM; Haghighi ZO; Sadr-Ameli MA
    Europace; 2008 May; 10(5):566-71. PubMed ID: 18390536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival.
    Wokhlu A; Rea RF; Asirvatham SJ; Webster T; Brooke K; Hodge DO; Wiste HJ; Dong Y; Hayes DL; Cha YM
    Heart Rhythm; 2009 Oct; 6(10):1439-47. PubMed ID: 19717348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.